Pathogenesis of vascular calcification in dialysis patients

Clinical and Experimental Nephrology

Volumn 9, Issue 4, 2005, Pages 265-270

  Ketteler, Markus ^a   Westenfeld, Ralf ^a   Schlieper, Georg ^a   Brandenburg, Vincent ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Fetuin A; Matrix Gla protein; Osteoprotegerin; Pyrophosphates; Vascular calcification

Indexed keywords

FETUIN; MATRIX PROTEIN; OSTEOPROTEGERIN; PYROPHOSPHATE;

AGE DISTRIBUTION; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; DIABETES MELLITUS; DISEASE SEVERITY; HEMODIALYSIS PATIENT; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; KIDNEY FAILURE; MORTALITY; NEPHROTIC SYNDROME; OSTEOBLAST; OSTEOPOROSIS; PATHOGENESIS; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; UREMIA; VASCULAR SMOOTH MUSCLE;

ANIMALS; ATHEROSCLEROSIS; CALCINOSIS; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS;

EID: 29144531174     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-005-0385-4     Document Type: Review

References (40)

1. US Renal Data System 1999 USRDS 1999 annual data report Am J Kidney Dis 34 2 suppl 1 S87 94
2. WG Goodman J Goldin BD Kuizon 2000 Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis N Engl J Med 342 1478 83
3. J Oh R Wunsch M Turzer M Bahner P Raggi U Querfeld 2002 Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure Circulation 106 100 5
4. J Blacher AP Guerin B Pannier 2001 Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease Hypertension 38 938 42
5. GM London AP Guerin SJ Marchais 2003 Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality Nephrol Dial Transplant 18 1731 40
6. SK Ganesh AG Stack NW Levin 2001 Association of elevated serum PO(4), Ca × PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients J Am Soc Nephrol 12 2131 8
7. GA Block PS Klassen JM Lazarus 2004 Mineral metabolism, mortality, and morbidity in maintenance hemodialysis J Am Soc Nephrol 15 2208 18
8. S Jono MD [tmp] McKee CE Murry 2000 Phosphate regulation of vascular smooth muscle cell calcification Circ Res 87 E10 17
9. NX Chen KD O'Neill D Duan SM Moe 2002 Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells Kidney Int 62 1724 31
10. SM Moe KD O'Neill D Duan 2002 Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins Kidney Int 61 638 47
11. SM Moe D Duan BP Doehle KD O'Neill NX Chen 2003 Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels Kidney Int 63 1003 11
12. JL Reynolds AJ Joannides JN Skepper 2004 Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD J Am Soc Nephrol 15 2857 67
13. M Ketteler C Wanner T Metzger P Bongartz R Westenfeld U Gladziwa 2003 Deficiencies of calcium-regulatory proteins in dialysis patients: a novel concept of cardiovascular calcification in uremia Kidney Int Suppl 84 S84 7
14. G Luo P Ducy MD [tmp] McKee GJ Pinero E Loyer RR Behringer 1997 Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein Nature 386 78 81
15. CM Shanahan NR Cary JC Metcalfe PL Weissberg 1994 High expression of genes for calcification-regulating proteins in human atherosclerotic plaques J Clin Invest 93 2393 402
16. WG Goodman G London K Amann GA Block C Giachelli KA Hruska 2004 Vascular Calcification Work Group. Vascular calcification in chronic kidney disease Am J Kidney Dis 43 572 9
17. LJ Schurgers KJ Teunissen MH Knapen P Geusens D van der Heijde M Kraijtaal 2005 Characteristics and performance of an immunosorbent assay for human matrix Gla-protein Clin Chim Acta 351 131 8
18. N Bucay I Sarosi CR Dunstan S Morony J Tarpley C Capparelli 1998 Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification Genes Dev 12 1260 8
19. WS Simonet DL Lacey CR Dunstan M Kelley MS Chang R Luthy 1997 Osteoprotegerin: a novel secreted protein involved in the regulation of bone density Cell 89 309 19
20. WJ Boyle WS Simonet DL Lacey 2003 Osteoclast differentiation and activation Nature 423 337 42
21. K Nitta T Akiba K Uchida A Kawashima W Yumura T Kabaya 2003 The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis Am J Kidney Dis 42 303 9
22. LC Hofbauer M Schoppet 2001 Osteoprotegerin: a link between osteoporosis and arterial calcification? Lancet 358 257 8
23. Harmey D, Hessle L, Narisawa S, Johnson KA, Terkeltaub R, Millan JL. Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders. Am J Pathol 2004;1199-209
24. AM Ho MD Johnson DM Kingsley 2000 Role of the mouse ank gene in control of tissue calcification and arthritis Science 289 265 70
25. F Rutsch N Ruf S Vaingankar MR Toliat A Suk W Hohne 2003 Mutations in ENPP1 are associated with "idiopathic" infantile arterial calcification Nat Genet 34 379 81
26. K Nitta T Akiba K Suzuki K Uchida R Watanabe K Majima 2004 Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis Am J Kidney Dis 44 680 8
27. F Gejyo JL Chang W Bürgi K Schmid GD Offner RF Troxler 1983 Characterization of the B-chain of human plasma α2HS-glycoprotein J Biol Chem 258 4966 71
28. Y Yoshioka F Gejyo T Marti EE Rickli W Bürgi GD Offner 1986 The complete amino acid sequence of the A-chain of human plasma α2HS- glycoprotein J Biol Chem 261 1665 76
29. JP Lebreton F Joisel JP Raoult 1979 Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant J Clin Invest 64 1118 29
30. M Demetriou C Binkert B Sukhu 1996 Fetuin/alpha2-HS glycoprotein is a transforming growth factor-beta type II receptor mimic and cytokine antagonist J Biol Chem 271 12755 61
31. ST Mathews GP Singh M Ranalletta 2002 Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene Diabetes 51 2450 8
32. C Schafer A Heiss A Schwarz 2003 The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification J Clin Invest 112 357 66
33. R Westenfeld C Smeets C Schäfer 2003 Extraosseous mRNA expression of bone associated proteins in uremic mice lacking Ahsg/fetuin-A Nephrol Dial Transplant 18 Suppl 4 593
34. MW Merx C Schafer R Westenfeld V Brandenburg S Hidajat C Weber 2005 Myocardial stiffness, cardiac remodeling, and diastolic dysfunction in calcification-prone fetuin-a-deficient mice J Am Soc Nephrol 16 3357 64
35. M Ketteler P Bongartz R Westenfeld 2003 Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study Lancet 361 827 33
36. P Stenvinkel K Wang AR Qureshi 2005 Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin Kidney Int 67 2383 92
37. SM Moe M Reslerova M Ketteler 2005 Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease Kidney Int 67 2295 304
38. R Mehrotra R Westenfeld P Christenson 2005 Serum fetuin-A in non-dialyzed patients with diabetic nephropathy: relationship with coronary artery calcification Kidney Int 67 1070 7
39. JJ Kazama F Gejyo I Ei 2005 The immunohistochemical localization of a2-Heremans-Schmid-glycoprotein/fetuin-A (AHSG) Nephrol Dial Transplant 20 851 2
40. BK Kishore F Gejyo M Arakawa 1983 Alpha2HS-glycoprotein in the serum and urine of patients with renal diseases Postgrad Med J 59 304 7